Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sorrento Therapeutics Inc (NQ: SRNE ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Feb 22, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Sorrento Therapeutics Inc < Previous 1 2 3 4 5 6 7 8 Next > Market Briefing For Monday, Aug. 2 August 02, 2021 We're 'not' in a global financial crisis; but we are failing the 'synchronized global recovery', due to the worldwide pandemic. Via Talk Markets Market Briefing For Thursday, July 29 July 29, 2021 Disarming SARS-CoV-2 with pharmaceutical drugs is the 'holy grail' to end the COVID-19 panic, and generally eliminate the panic pressures for vaccines. Via Talk Markets Exposures COVID-19 Market Briefing For Wednesday, July 28 July 28, 2021 Tolls being taken out of the market for those overstaying not just Chinese stocks, but the S&P and NDX behemoths as well. Solid earnings are 'in the mix' (discounted) of course, and it's the guidance... Via Talk Markets Topics Stocks Exposures US Equities Market Briefing For Thursday, July 22 July 22, 2021 The post-COVID era has not arrived yet, and that cuts to the chase of what's bothering markets and prospects for the economy. The optimistic hope is to keep everything open on a presumed basis, because... Via Talk Markets Topics Economy Exposures Economy Unusual Options Activity Insight: Sorrento Therapeutics July 21, 2021 Shares of Sorrento Therapeutics (NASDAQ:SRNE) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $9.16. Sentiment:... Via Benzinga Why Sorrento Therapeutics' Stock Is Trading Higher Today July 21, 2021 Sorrento Therapeutics (NASDAQ:SRNE) shares are trading hig... Via Benzinga Market Briefing For Wednesday, July 21 July 21, 2021 Via Talk Markets Delta Variant Infections of COVID Rising Quickly & Now Responsible for 83% of All U.S. Cases July 22, 2021 Via FinancialNewsMedia Exposures COVID-19 Sorrento Starts Patient Dosing In Mid-Stage COVID-19 Trial With Nasal Neutralizing Antibody July 21, 2021 Sorrento Therapeutics Inc (NASDAQ: SRNE) has started dosing COVID-19 patients in its Phase 2 efficacy trial. This study uses a decentralized design where... Via Benzinga Exposures COVID-19 Market Briefing For Wednesday, July 14 July 14, 2021 Negative divergences increasingly creeping into the NY market are reflected a good bit by the S&P shuffles, and overall big-board technicals. Though, yields were up with a mediocre Treasury Auction,... Via Talk Markets Topics Stocks Exposures US Equities Unusual Options Activity Insight: Sorrento Therapeutics July 12, 2021 On Monday, shares of Sorrento Therapeutics (NASDAQ:SRNE) saw unusual options activity. After the option alert, the stock price moved down to $8.31. Sentiment: BULLISH Option... Via Benzinga Why Sorrento Therapeutics Is Down 9% This Week July 08, 2021 Investors apparently weren't impressed by good news about the company's promising RTX. Via The Motley Fool Why Sorrento Therapeutics Stock Gained 29% Last Month July 08, 2021 The rally has more to do with the stock's pre-June circumstances than recent news. Via The Motley Fool Exposures COVID-19 Market Briefing For Thursday, July 8 July 08, 2021 Economic instability was a concern of the FOMC Minutes, with debates as to whether or not the country is recovering faster than they expected. Via Talk Markets 12 Health Care Stocks Moving In Wednesday's Intraday Session July 07, 2021 Gainers Opiant Pharmaceuticals (NASDAQ:OPNT Via Benzinga Sorrento To Start Testing Non-Opioid Candidate In Osteoarthritis-Related Knee Pain July 07, 2021 The FDA has signed off Sorrento Therapeutics Inc's (NASDAQ: SRNE) Phase 2 study of Resiniferatoxin (RTX) for moderate-to-severe osteoarthritis of the knee pain... Via Benzinga Exposures Product Safety Why Sorrento Therapeutics Is Climbing Today July 01, 2021 Rising numbers of new COVID-19 cases might have investors anticipating strong demand for the company's 15-minute test. Via The Motley Fool Exposures COVID-19 Cramer Gives His Opinion On Virgin Galactic, Zynex And More July 01, 2021 On CNBC's "Mad Money Lightning Round," Jim Cramer said Virgin Galactic Holdings Inc (NYSE: SPCE) is a very expensive stock. It had a nice run, but he would look for... Via Benzinga Market Briefing For Thursday, July 1 July 01, 2021 The second quarter of 2021 concluded on a high note, a new record S&P high, which was a part of Wednesday's rotational action focused primarily on big cap stocks influential enough to contribute to the... Via Talk Markets Topics Stocks Exposures US Equities Sorrento Therapeutics Forms Bullish Pattern, Options Traders Place Bets June 28, 2021 Sorrento Therapeutics, Inc (NASDAQ:SRNE) shot up over 10% ... Via Benzinga 20 Stocks Moving in Friday's Pre-Market Session June 25, 2021 Gainers Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) rose 83.4% to $16.34 in pre-market trading after the company reported a sharp rise in Q1 earnings and sales. Grove, Inc. (... Via Benzinga Why Sorrento Therapeutics Stock Jumped 10.6% Today June 24, 2021 The company is setting up a subsidiary to launch its COVID-19 test in Mexico. Via The Motley Fool Exposures COVID-19 The News That Has Sorrento Therapeutics Trading Higher Today June 24, 2021 Sorrento Therapeutics Inc (NASDAQ: SRNE) is trading higher Thursday after the company received EUA approval and a product import license from COFEPRIS for its rapid COVID-19 test... Via Benzinga Exposures COVID-19 Market Briefing For Thursday, Jun. 24 June 24, 2021 Around record S&P levels, discussions drone-on about crypto or the Fed, and inflation, along with vague discussions about returning risk from COVID. Via Talk Markets Topics Economy Stocks Exposures Interest Rates US Equities Market Briefing For Wednesday, Jun. 23 June 23, 2021 The attractiveness of stocks and sectors vary so widely now, that most bull / bear debates are somewhat academic, even though logic for a correction is there. Via Talk Markets Sorrento Therapeutics Is Forming Pennant Pattern: Technical Levels To Watch June 22, 2021 Sorrento Therapeutics Inc. (NASDAQ: SRNE) shares moved higher Tuesday after the company announced Phase 2 Abivertinib clinical studies have completed patient enrollment in the U.S... Via Benzinga Sorrento Therapeutics Concludes Enrollment In Abivertinib Mid-Stage COVID-19 Trials In US, Brazil June 22, 2021 Sorrento Therapeutics Inc (NASDAQ: SRNE) has completed enrollment for its Phase 2 trial of Abivertinib in hospitalized COVID-19 patients in Brazil. This... Via Benzinga Exposures COVID-19 Market Briefing For Thursday, Jun. 17 June 17, 2021 Vulnerability is bifurcated, just like sector rotation indicated all year thus far. It is typical to see risk increased amidst superficial optimism at high S&P levels, but that's not really what moved... Via Talk Markets Topics Stocks Exposures US Equities Market Briefing For Tuesday, Jun. 15 June 15, 2021 Conclusions can't be drawn about the upcoming FOMC meetings by analysts, who mostly continue to debate the issues we know: hot inflation numbers that skewed the CPI, whether that's transitory or not,... Via Talk Markets Why Sorrento Therapeutics Stock Flew Nearly 7% Higher on Monday June 14, 2021 The company got the green light to launch phase 2 testing in the U.K. for its experimental COVID-19 treatment. Via The Motley Fool Exposures COVID-19 < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.